Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|17|2291-2303

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.17, 2015-05, pp. : 2291-2303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Progress in the Discovery of Non-Sarcosine Based GlyT1 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 170-186

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Preparation and Testing of Glycine Transporter Type-1 (GlyT1) Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 17, 2006-09 ,pp. : 1883-1896

Bentham Science Publishers

Access to resources Recommend Favorite

Novel inhibitors of the type 1 transporter for glycine (GlyT1) as antipsychotic agents

By Lowe III John A  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 11, 2005-11 ,pp. : 1657-1662

Informa Healthcare

Access to resources Recommend Favorite

Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1311-1320

Bentham Science Publishers

Access to resources Recommend Favorite

Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat

By Black Mark   Varty Geoffrey   Arad Michal   Barak Segev   Levie Amaya   Boulay Denis   Pichat Philippe   Griebel Guy   Weiner Ina  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 385-396

Springer Publishing Company

Access to resources Recommend Favorite